ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 626167 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 626167; 2) Community: the network communities that were significantly associated with the response to NSC 626167; 3) Molecule: the relationships between components within communities and NSC 626167; 4) MDR: the compounds that were significantly associated with the NSC 626167.

NSC Compound Enrichment Correlation
NSC 132313 Dianhydrogalactitol 0.0114553853234977 0.18029689
NSC 135880 Null 0.0114553853234977 0.35564187
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0114553853234977 0.10175777
NSC 22709 v-Triazolo[4,5-d]pyrimidin-7-ol 0.0114553853234977 0.38908564
NSC 254665 JUSTICIDIN B 0.0114553853234977 0.26400907
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0114553853234977 0.23733898
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0114553853234977 0.16144305
NSC 47468 Null 0.0114553853234977 0.22838392
NSC 603071 Aminocamptothecin 0.0114553853234977 0.12151136
NSC 603578 Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) 0.0114553853234977 0.28576325
Total:87  Current:27    [First] [Prev] [Next] [Last]